Sigma Healthcare
Sigma Healthcare is a leading Australian retail pharmacy franchisor and full-line pharmaceutical wholesaler and distributor. They support a large retail network of franchised pharmacies, including Chemist Warehouse, Amcal, and Discount Drug Stores. In February 2025, Sigma merged with Chemist Warehouse Group, combining Sigma's distribution infrastructure with Chemist Warehouse's retail expertise.
Short position
Sigma Healthcare (ASX:SIG) has 5.46% of its shares on issue reported as short positions as of 5 Oct 2026, or about 630,631,230 shares. Over the past 30 days that figure has risen 1.14 percentage points, and over 90 days it has risen 1.97 percentage points. Its highest recorded short interest was 7.54% in July 2018. SIG is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Sigma Healthcare (SIG) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $10.83Bvs $6.00B (FY25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- $709.2Mvs $529.9M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- $0.062T (source: Derived: trailing 12 months at year end)vs $0.051 (FY25)
- Derived: trailing 12 months at year end, as at 29 Sep 2026
- Rev YoY
- +80.5%FY
- EPS YoY
- +21.6%FY
- Derived: trailing 12 months at year end
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 18.1%
- Operating margin
- 8.4%
- Net margin
- 6.5%
- FCF margin
- 4.8%
- ROE
- 14.7%
- ROA
- 8.2%
- FCF conversion
- 0.73×
- Net debt (excl. leases)
- $663.2M
- Net debt / EBITDA
- 0.6×
- Current ratio
- 1.7×
- Interest cover
- 19.5×
- Cash dividends paid / net profit
- 53.4%
- Market cap
- $30.94B
- P/E
- 43.4×
- P/B
- 6.2×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY25 | FY24 |
|---|---|---|---|---|
| Revenue | $10.83B | $6.00B | $4.85B | $3.38B |
| Gross profit | $1.96B | $1.44B | $334.1M | $271.9M |
| Operating income | $907.0M | $666.6M | −$10.1M | −$18.2M |
| EBITDA | $1.14B | $832.6M | $55.5M | $53.3M |
| EBIT | $1.05B | $776.6M | $29.7M | $24.9M |
| Interest expense | $46.4M | $33.1M | $18.5M | $16.3M |
| Pretax income | $1.01B | $743.5M | $11.1M | $8.6M |
| Tax | $296.4M | $218.0M | $24.1M | $3.3M |
| NPAT | $709.2M | $529.9M | −$13.8M | $4.5M |
| Net interest income | −$51.8M | −$24.4M | −$10.5M | −$14.6M |
| EPS basic | $0.062T (source: Derived: trailing 12 months at year end) | $0.051 | −$0.009 | $0.004 |
| EPS diluted | $0.062T (source: Derived: trailing 12 months at year end) | $0.051 | −$0.009 | $0.004 |
| Shares | 11.50B | 11.50B | 1.63B | 1.63B |
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Sigma Full Year Results PresentationFull Year Results27 Aug 2026via asx_announcements
- 2026 Appendix 4E and Annual ReportAnnual Results27 Aug 2026via asx_announcements
- Sigma Full Year Results ASX ReleaseFull Year Results27 Aug 2026via asx_announcements
- Sigma FY26 Full Year Results InformationFull Year Results14 Aug 2026via asx_announcements
- FY26 Full Year Results Announcement DateFull Year Results2 Jul 2026via asx_announcements
- Sigma Half Year Results PresentationHalf Year Results26 Feb 2026via asx_announcements
- Sigma Half Year Results ASX ReleaseHalf Year Results26 Feb 2026via asx_announcements
- Half Year AccountsHalf Year Results26 Feb 2026via asx_announcements
- FY26 Half Year Results InformationHalf Year Results19 Feb 2026via asx_announcements
- FY26 Half Year Results announcement dateHalf Year Results13 Jan 2026via asx_announcements
Showing 10 of 25 reports